Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon

Age: 18 years and over

Healthy Volunteers:

This study is NOT accepting healthy volunteers

Inclusion Criteria:

• Previous diagnosis of cystic fibrosis (CF) or chronic pancreatitis (CP).
• Previous diagnosis of exocrine pancreatic insufficiency (EPI) that is currently clinically controlled.
• Total Symptom Score (TSS) < 1.8 on Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q) at Screening.

Exclusion Criteria:

• Malignancy involving the digestive tract in the last 5 years, or other significant disease or medical condition that may interfere with EPI symptom assessment.

Interventions:

Drug: CREON

Conditions:

Cystic Fibrosis, Chronic Pancreatitis

Keywords:

Cystic Fibrosis, Chronic Pancreatitis, Exocrine Pancreatic Insufficiency, Creon, Pancrelipase

Contact(s): ABBVIE CALL CENTER - abbvieclinicaltrials@abbvie.com

Principal Investigator: Chaudary, Nauman

Phase: Phase 4

IRB Number: HM20025086

System ID: NCT05069597

See this study on ClinicalTrials.gov

Thank you for choosing StudyFinder. Please visit http://studyfinder.cctr.vcu.edu to find a Study which is right for you and contact ctrrecruit@vcu.edu if you have questions or need assistance.

Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon

Email this study information to me

Contact the study team